Premium
Clinician factors associated with prescribing nicotine replacement therapy in pregnancy: A cross‐sectional survey of Australian obstetricians and general practitioners
Author(s) -
BarZeev Yael,
Bonevski Billie,
Gruppetta Maree,
Twyman Laura,
Atkins Lou,
Palazzi Kerrin,
Oldmeadow Christopher,
Gould Gillian S.
Publication year - 2018
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/ajo.12751
Subject(s) - medicine , nicotine replacement therapy , cross sectional study , family medicine , odds ratio , medical prescription , pregnancy , odds , nicotine , nursing , psychiatry , logistic regression , pathology , biology , genetics
The use of nicotine replacement therapy in pregnancy has been debated but evidence suggests that it is safer than smoking. A cross‐sectional survey was conducted with: (i) general practitioners and obstetricians from a college database; and (ii) general practitioners with a special interest in Indigenous health. General practitioners had higher odds of prescribing compared to obstetricians. Reading guidelines, confidence, viewing nicotine replacement therapy as safe, effective and with good adherence, also significantly increased the odds of prescription. Clear guidance regarding safety and efficacy, with practical clinical protocols, are required in order to reduce variation in prescribing rates across these clinicians.